4Filed Aug 13, 8:00 PM ET

SOPHiA GENETICS (SOPH) CSO Xu Zhenyu Sells 4,000 Shares

$SOPH · SOPHiA GENETICS SA

Research Summary

AI-generated summary of this SEC filing

Updated

SOPHiA GENETICS (SOPH) CSO Xu Zhenyu Sells 4,000 Shares

What Happened

  • Xu Zhenyu, Chief Scientific Officer of SOPHiA GENETICS SA (SOPH), disposed of 4,000 shares on 2026-08-13. The reported weighted-average price was $7.52 per share, for total proceeds of $30,076. The transaction is coded as a sale (S).

Key Details

  • Transaction date: 2026-08-13; Form 4 filed 2026-08-14 (filed next day — timely under the Form 4 2-business-day rule).
  • Price: weighted average $7.52; shares sold in multiple trades at prices ranging $7.43–$7.62 (footnote offers breakdown on request).
  • Shares sold: 4,000; total proceeds: $30,076.
  • Shares owned after transaction: not disclosed in this filing.
  • Notable footnotes: F1 — sale was made pursuant to a pre-established Rule 10b5-1(c) trading plan; F2 — weighted-average price with multi-price sale range and offer to provide per-price breakdown on request.

Context

  • The sale was made under a 10b5-1 plan, which is a prearranged trading program that can help insiders sell shares on a set schedule. Such preplanned sales are common and do not by themselves indicate insider sentiment. The amount ($30k) is relatively small; retail investors should treat this as routine insider liquidity unless accompanied by other material signals.